Release Date: 24/12/15 10:48 Summary: Statement regarding Ferrovial Replacement Bidders Statement Price Sensitive: Yes Download Document 69.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%